Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1
- PMID: 1618746
Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1
Abstract
In humans and non-human primates, alternative cleavage and polyadenylation of plasminogen activator inhibitor type-1 (PAI-1) pre-mRNA transcripts results in two forms of mature mRNA, an unstable 3.2-kilobase (kb) form, and a relatively more stable 2.2-kb form. Insulin and insulin-like growth factor I (IGF-1) increase steady state levels of PAI-1 mRNA in Hep G2 cells independently and synergistically. In the present study we found that the rate of transcription of the PAI-1 gene is not affected by insulin, IGF-1, or both but that insulin prolongs the half-life of the 3.2-kb PAI-1 mRNA species 2.7-fold without affecting the half-life of the 2.2-kb species. In contrast IGF-1, alone or with insulin, markedly prolongs the half-lives of both species. Our results demonstrate a novel mechanism of regulation of expression of the PAI-1 gene by insulin and IGF-1 operating at the post-transcriptional level.
Similar articles
-
Different induction of two plasminogen activator inhibitor 1 mRNA species by phorbol ester in human hepatoma cells.J Biol Chem. 1991 Sep 25;266(27):17845-9. J Biol Chem. 1991. PMID: 1655729
-
Transcriptional regulation of plasminogen activator inhibitor type-1 mRNA in Hep G2 cells by epidermal growth factor.Nucleic Acids Res. 1991 Jan 11;19(1):163-8. doi: 10.1093/nar/19.1.163. Nucleic Acids Res. 1991. PMID: 2011496 Free PMC article.
-
Control of plasminogen-activator inhibitor type 2 gene expression in the differentiation of monocytic cells.Eur J Biochem. 1992 Apr 1;205(1):203-9. doi: 10.1111/j.1432-1033.1992.tb16769.x. Eur J Biochem. 1992. PMID: 1555580
-
Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states.Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):9959-63. doi: 10.1073/pnas.88.22.9959. Proc Natl Acad Sci U S A. 1991. PMID: 1719559 Free PMC article.
-
Multiple transforming growth factor-beta-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells.J Biol Chem. 1991 Jan 15;266(2):1092-100. J Biol Chem. 1991. PMID: 1985937
Cited by
-
Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease.J Thromb Thrombolysis. 2001 May;11(3):183-93. doi: 10.1023/a:1011955018052. J Thromb Thrombolysis. 2001. PMID: 11577256 Review.
-
Post-transcriptional regulation of plasminogen activator inhibitor type-1 expression in human pleural mesothelial cells.Am J Respir Cell Mol Biol. 2010 Sep;43(3):358-67. doi: 10.1165/rcmb.2009-0046OC. Epub 2009 Oct 23. Am J Respir Cell Mol Biol. 2010. PMID: 19855086 Free PMC article.
-
Angiotensin II induces renal plasminogen activator inhibitor-1 and cyclooxygenase-2 expression post-transcriptionally via activation of the mRNA-stabilizing factor human-antigen R.Am J Pathol. 2009 Apr;174(4):1252-63. doi: 10.2353/ajpath.2009.080652. Epub 2009 Feb 26. Am J Pathol. 2009. PMID: 19246637 Free PMC article.
-
Endothelial dysfunction in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: current knowledge and novel biomarkers.Front Endocrinol (Lausanne). 2025 Jun 3;16:1581681. doi: 10.3389/fendo.2025.1581681. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40529825 Free PMC article. Review.
-
PAI-1 and diabetes: a journey from the bench to the bedside.Diabetes Care. 2012 Oct;35(10):1961-7. doi: 10.2337/dc12-0638. Diabetes Care. 2012. PMID: 22996180 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous